Clinical Trials Browser

Phase 1 × Interventional × Inflammatory Bowel Diseases × Clear all

NCT03816345 2026-05-13

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Dermatomyositis, Lupus Erythematosus, Systemic, Multiple Sclerosis, Psoriasis, Scleroderma, Systemic, Sjogren's Syndrome, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Hematologic Neoplasms

NCT02156557 2017-04-04

KCC 1B

Phase 1 Completed

45 enrolled

Gastrointestinal

Colonic Polyps, Colorectal Neoplasms, Inflammatory Bowel Diseases